MeiraGTx Holdings (MGTX)

• Market cap: $680M
• 1 day: -5.06%
• 5 days: 0.12%
• 1 month: 7.23%
• 3 months: 15.44%
• 6 months: 27.64%
• Year to date: 34.77%
• 1 year: 34.55%
• 5 years: -38.81%
• 10 years: -43.67%
• Sector: Healthcare
• Industry: Biotechnology

About: MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Employees: 409